scout

Ernest T. Hawk, MD, MPH

Articles by Ernest T. Hawk, MD, MPH

Strategies for chemopreventative drug development are based on the use of well-characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable cohorts for efficacy studies. Since